{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:21Z","timestamp":1784751861725,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mayocpiqo.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T08:35:07Z","timestamp":1617870907000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-2242","authenticated-orcid":false,"given":"Robert W.","family":"Kirchoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhan M.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-232X","authenticated-orcid":false,"given":"Jack","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-5497","authenticated-orcid":false,"given":"Matej","family":"Markota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-8988","authenticated-orcid":false,"given":"Thomas","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-9375","authenticated-orcid":false,"given":"Jonathan","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Caroline","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-385X","authenticated-orcid":false,"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.01.013_bib1","doi-asserted-by":"crossref","first-page":"e1921451","DOI":"10.1001\/jamanetworkopen.2019.21451","article-title":"Trends in alcohol-induced deaths in the United States, 2000-2016","volume":"3","author":"Spillane","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mayocpiqo.2021.01.013_bib2","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National Survey on Drug Use and Health","year":"2019"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.01.013_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.01.013_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/alcalc\/agy024","article-title":"Predictors of alcohol withdrawal readmissions","volume":"53","author":"Yedlapati","year":"2018","journal-title":"Alcohol Alcohol"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2021.01.013_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"22","key":"10.1016\/j.mayocpiqo.2021.01.013_bib6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1001\/jama.2017.4760","article-title":"More treatments on deck for alcohol use disorder","volume":"317","author":"Lyon","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.01.013_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/HRP.0000000000000079","article-title":"Pharmacotherapy for alcohol use disorder: current and emerging therapies","volume":"23","author":"Swift","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"18","key":"10.1016\/j.mayocpiqo.2021.01.013_bib8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.mayocpiqo.2021.01.013_bib9","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocpiqo.2021.01.013_bib10","article-title":"Medications can aid recovery from alcoholism","author":"Kurtzweil","year":"1996","journal-title":"FDA Consumer Magazine"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.01.013_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.01.013_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mayocpiqo.2021.01.013_bib13","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","volume":"1","author":"Srisurapanont","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocpiqo.2021.01.013_bib14","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.01.013_bib15","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.01.013_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11606-014-2968-9","article-title":"An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits","volume":"30","author":"Wei","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.01.013_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12788\/jhm.2900","article-title":"Implementation of a process for initiating naltrexone in patients hospitalized for alcohol detoxification or withdrawal","volume":"13","author":"Stephens","year":"2018","journal-title":"J\u00a0Hosp Med"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.01.013_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans Health Administration","volume":"61","author":"Harris","year":"2010","journal-title":"Psychiatric Serv"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.01.013_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.15288\/jsa.1994.55.561","article-title":"Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients","volume":"55","author":"Moos","year":"1994","journal-title":"J\u00a0Stud Alcohol"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.01.013_bib20","first-page":"307","article-title":"Epidemiology of alcohol withdrawal syndrome: mortality and factors of poor prognosis [in Spanish]","volume":"23","author":"Louro Puerta","year":"2006","journal-title":"An Med Interna"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.01.013_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pec.2008.11.002","article-title":"Teachable moments for health behavior change: a concept analysis","volume":"76","author":"Lawson","year":"2009","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.01.013_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14740338.2018.1404025","article-title":"Alcohol addiction\u2014the safety of available approved treatment options","volume":"17","author":"Antonelli","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.01.013_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1360-0443.2004.00964.x","article-title":"Recovery from DSM-IV alcohol dependence: United States, 2001-2002","volume":"100","author":"Dawson","year":"2005","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.01.013_bib24","doi-asserted-by":"crossref","first-page":"810-818","DOI":"10.1176\/appi.ps.201600339","article-title":"Reducing behavioral health inpatient readmissions for people with substance use disorders: do follow-up services matter?","volume":"68","author":"Reif","year":"2017","journal-title":"Psychiatr Serv"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:09:27Z","timestamp":1762870167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454821000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2542454821000321"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.01.013","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}